We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.
Journal article
Eur J Haematol
08/2020
105
231 - 233
DPACE, DTPACE, VRDPACE, VTDPACE, efficacy, myeloma, survival, Antineoplastic Combined Chemotherapy Protocols, Cisplatin, Cyclophosphamide, Doxorubicin, Etoposide, Humans, Multicenter Studies as Topic, Multiple Myeloma, Prognosis, Treatment Outcome, United Kingdom